# NALTREXONE
> **ANDA213195** · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2023-07-06
## Drug
- **FDA Application Number:** ANDA213195
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** NALTREXONE
- **Generic name:** Naltrexone
- **Active ingredients:** NALTREXONE
- **Dosage form:** FOR SUSPENSION, EXTENDED RELEASE
- **Route:** INTRAMUSCULAR
- **Marketing status:** Discontinued
- **Sponsor:** TEVA PHARMS USA INC
- **First approval:** 2023-07-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213195)
---
*AI Analytics · CC0 1.0*